Cornea strengthening treatment study for thinning corneas
Part of Eyes & vision clinical trials.
This Phase 2 study tests whether a procedure called PXL‑Platinum 330 can safely and effectively strengthen corneas that are thinning (such as keratoconus or related conditions). It aims to see if the treatment can help stabilize or improve the cornea’s shape while keeping side effects low.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be age 18 or older
- You need one or both eyes with signs of cornea thinning (for example keratoconus or pellucid marginal degeneration) based on eye scans and exam
- Your cornea measurements must meet specific minimum/maximum thresholds (such as minimum thickness and elevation on scan)
- You must be able to follow the study schedule and use eye drops/appointments as instructed
- If you wear contact lenses, you must stop them for the required time before screening (varies by lens type)
- You must sign a written informed consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests how safe and well a corneal cross-linking device (called PXL-Platinum 330) works for people with corneal ectasia (a thinning/steepening of the cornea). If you qualify, the goal is to help stop or slow further worsening of your cornea shape and improve eye stability.
This trial studies collagen cross-linking, a procedure meant to strengthen a weakened cornea in people with keratoconus. It may help slow the bulging/weakening of the cornea and improve vision, and the study also uses special imaging to check changes over time.
This trial tests two different laser-based procedures to treat keratoconus, a condition that weakens and bulges the cornea. The goal is to see which approach better strengthens the eye and improves vision.
This study tests a procedure called Xenia corneal lenticule in people with severe keratoconus or severe post-LASIK corneal thinning who want to avoid a corneal transplant. It aims to improve vision while checking safety and how well the new procedure works over time.
This trial tests a new combined treatment for keratoconus that includes both a surface laser (phototherapeutic keratectomy) and corneal collagen crosslinking (CXL). It may help strengthen your cornea and improve vision.
This study looks at how donor corneas (for deep lamellar corneal transplant in keratoconus) are prepared using corneal collagen cross-linking, to see if it improves outcomes for people with keratoconus. You may be eligible if you meet vision and cornea shape/thickness requirements and can return for long follow-up.
Hear when a new Keratoconus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.